Nasdaq: BridgeBio Pharma Announces $500 Million Convertible Senior Notes Offering to Strengthen Balance Sheet and Enhance Financial Flexibility
BridgeBio Pharma plans to offer $500 million in convertible senior notes, aiming to strengthen its financial position and reduce interest expenses. BridgeBio Pharma, Inc. announced plans to offer $500 ...
BridgeBio Pharma Announces $500 Million Convertible Senior Notes Offering to Strengthen Balance Sheet and Enhance Financial Flexibility
Nasdaq: BridgeBio Pharma, Inc. Prices $500 Million Convertible Senior Notes Offering to Lower Debt and Enhance Financial Flexibility
BridgeBio Pharma, Inc. has announced the pricing of $500 million in convertible senior notes at a 1.75% interest rate, maturing in 2031, in a private offering aimed at qualified institutional buyers.
BridgeBio Pharma, Inc. Prices $500 Million Convertible Senior Notes Offering to Lower Debt and Enhance Financial Flexibility
MedCity News: The Financial Potential of Convertible Notes in the Pharmaceutical Sector
Yahoo Finance: IGC Pharma Notes Updated Research Coverage from Ascendiant Capital Markets
A pharmaceutical is a substance used in the diagnosis, treatment, or prevention of disease and for restoring, correcting, or modifying organic functions.
The pharmaceutical industry entails the discovery, development, and manufacture of drugs and medications (pharmaceuticals) by public and private organizations.
The Sackler family formerly owned the pharmaceutical company Purdue Pharma, known for developing the highly addictive drug OxyContin. They gave up control of the company in 2025 as part of a settlement for their involvement in the opioid epidemic.
Dilip Shanghvi (born , Amreli, Gujarat state, India) is an Indian business executive who was the founder (1983) of Sun Pharmaceutical Industries Ltd. The son of a wholesale drug distributor, Shanghvi launched Sun Pharma soon after graduating (1982) from the University of Calcutta with a bachelor’s degree in commerce. He assumed the post of managing director. Initially, the ...